Shanghai RAAS Blood Products Co Ltd Class A Capital Reinvestment Ratio
Shanghai RAAS Blood Products Co Ltd Class A capital reinvestment ratio. Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Capital Reinvestment Ratio of 0.08x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥775.56 Million) in capital expenditures (CN¥62.51 Million). Check Shanghai RAAS Blood Products Co Ltd Clas cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Capital reinvestment ratio of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2023. This chart tracks Shanghai RAAS Blood Products Co Ltd Class A's Capital Reinvestment Ratio across 18 annual periods. Also explore Shanghai RAAS Blood Products Co Ltd Clas (002252) equity growth momentum to track the company's year-over-year net asset growth rate.
Shanghai RAAS Blood Products Co Ltd Class A Capital Reinvestment Ratio by Year (2005–2023)
Shanghai RAAS Blood Products Co Ltd Class A capital reinvestment ratio by year from 2005 to 2023. For the full cash flow conversion analysis, see Shanghai RAAS Blood Products Co Ltd Clas (002252) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.20x | CN¥2.28 Billion | CN¥450.80 Million | ▲ +51.3% |
| 2022 | 0.13x | CN¥1.73 Billion | CN¥225.73 Million | ▼ -17.3% |
| 2021 | 0.16x | CN¥1.29 Billion | CN¥204.61 Million | ▼ -26.6% |
| 2020 | 0.22x | CN¥1.17 Billion | CN¥251.76 Million | ▲ +21.4% |
| 2019 | 0.18x | CN¥872.69 Million | CN¥154.84 Million | ▼ -70.3% |
| 2018 | 0.60x | CN¥262.50 Million | CN¥156.94 Million | ▲ +1.8% |
| 2017 | 0.59x | CN¥268.76 Million | CN¥157.84 Million | ▲ +154.2% |
| 2016 | 0.23x | CN¥638.22 Million | CN¥147.49 Million | ▲ +21.2% |
| 2015 | 0.19x | CN¥762.42 Million | CN¥145.39 Million | ▲ +36.6% |
| 2014 | 0.14x | CN¥465.96 Million | CN¥65.06 Million | ▼ -75.4% |
| 2012 | 0.57x | CN¥263.46 Million | CN¥149.70 Million | ▼ -42.8% |
| 2011 | 0.99x | CN¥178.03 Million | CN¥176.80 Million | ▲ +122.9% |
| 2010 | 0.45x | CN¥200.21 Million | CN¥89.21 Million | ▼ -15.2% |
| 2009 | 0.53x | CN¥116.01 Million | CN¥60.99 Million | ▲ +93.6% |
| 2008 | 0.27x | CN¥107.64 Million | CN¥29.23 Million | ▲ +95.1% |
| 2007 | 0.14x | CN¥175.71 Million | CN¥24.46 Million | ▼ -38.3% |
| 2006 | 0.23x | CN¥53.58 Million | CN¥12.08 Million | ▼ -43.8% |
| 2005 | 0.40x | CN¥54.02 Million | CN¥21.69 Million | — |